WindRose Health Investors Makes Strategic Investment in CIVIE

WindRose Health Investors Makes Majority Growth Investment in SubjectWell

April 30, 2024

Healthcare Services

WindRose Health Investors completed a majority growth investment in SubjectWell, the patient-access marketplace that connects motivated patients to clinical trials and treatments. Terms were not disclosed; SubjectWell's management will remain in place and as active shareholders while WindRose provides growth capital to accelerate product development, machine learning and marketplace expansion.

WindRose Health Investors Recapitalizes Veristat Group Inc.

April 7, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.

Blue Wolf Capital to Acquire CIVCO Radiotherapy from Roper Technologies

October 22, 2021

Medical Devices

Blue Wolf Capital Partners has agreed to acquire CIVCO Radiotherapy, a maker of radiotherapy patient positioning and immobilization equipment, from Roper Technologies. CIVCO Radiotherapy, headquartered in Iowa with ~115 employees and serving hospitals and cancer centers globally, will be led by Nat Geissel as CEO following close; terms were not disclosed and the deal is expected to close by year-end.

WindRose Health Investors Invests in Stellus Rx

December 8, 2025

Healthcare Services

WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.

WindRose Health Investors Acquires CardioOne

March 4, 2024

Healthcare Services

WindRose Health Investors has completed the acquisition of CardioOne, a physician-enablement company serving independent cardiologists, and partnered with CardioOne's executive team to provide up to $100 million of additional capital to support growth. CardioOne's existing management will remain in place and the investment will fund expansion and enhancement of its technology platform and service offerings as the company prepares for value-based care.

WindRose Health Investors and Francisco Partners Invest in Avalon Healthcare Solutions

January 12, 2026

Healthcare Services

WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.